Comparison of central sensitization-related symptoms and health-related quality of life between breast cancer survivors with and without chronic pain and healthy controls
- PMID: 31127501
- DOI: 10.1007/s12282-019-00979-y
Comparison of central sensitization-related symptoms and health-related quality of life between breast cancer survivors with and without chronic pain and healthy controls
Abstract
Background: In breast cancer survivors, multiple risk factors for health-related quality of life (HRQoL) and chronic pain, including cancer treatment-related factors, psychosocial factors, and central sensitization (CS), have been suggested; however, there has been no comparative study between breast cancer survivors with and without pain. This study aimed to compare the demographic characteristics, psychological factors, and CS-related symptoms between breast cancer survivors with pain, those without pain, and healthy controls, and to investigate the relationships of these factors with HRQoL.
Methods: We conducted a cross-sectional survey of 218 women, including patients who underwent breast cancer surgery and adjuvant therapy and healthy women.
Results: Patients were divided into the pain group (n = 42), without-pain group (n = 51), and healthy group (n = 47); thus, among breast cancer survivors, 45% reported chronic pain. The proportion of participants who received breast cancer treatments, such as axillary lymph node dissection and chemotherapy, was higher in the pain group than in the without-pain group (p < 0.05). The Central Sensitization Inventory (CSI) and psychosocial factors in the pain group were higher than those in the without-pain group and healthy group (p < 0.01). The CSI and PCS showed larger effect sizes than treatment-related factors. Moreover, HRQoL was significantly correlated with CSI, PCS, Patient Health Questionnaire-2, and Generalized Anxiety Disorder-2 scale (all, p < 0.01). On multiple linear regression analysis, CSI accounted for 43% of the variance in HRQoL.
Conclusions: CS and pain catastrophizing may be more associated with the development and/or maintenance of persistent pain than treatment-related factors.
Keywords: Breast cancer; Cancer pain; Central Sensitization Inventory; Central sensitization; Quality of life.
Similar articles
-
Unraveling Self-Reported Signs of Central Sensitization in Breast Cancer Survivors with Upper Limb Pain: Prevalence Rate and Contributing Factors.Pain Physician. 2018 May;21(3):E247-E256. Pain Physician. 2018. PMID: 29871380
-
Use of the Central Sensitization Inventory (CSI) as a treatment outcome measure for patients with chronic spinal pain disorder in a functional restoration program.Spine J. 2017 Dec;17(12):1819-1829. doi: 10.1016/j.spinee.2017.06.008. Epub 2017 Jun 12. Spine J. 2017. PMID: 28619687
-
Chronic Pain in Breast Cancer Survivors: Nociceptive, Neuropathic, or Central Sensitization Pain?Pain Pract. 2019 Feb;19(2):183-195. doi: 10.1111/papr.12732. Epub 2018 Nov 15. Pain Pract. 2019. PMID: 30269431
-
Do "central sensitization" questionnaires reflect measures of nociceptive sensitization or psychological constructs? A systematic review and meta-analyses.Pain. 2023 Jun 1;164(6):1222-1239. doi: 10.1097/j.pain.0000000000002830. Epub 2022 Nov 29. Pain. 2023. PMID: 36729810
-
Tests for central sensitization in general practice: a Delphi study.BMC Fam Pract. 2021 Oct 19;22(1):206. doi: 10.1186/s12875-021-01539-0. BMC Fam Pract. 2021. PMID: 34666688 Free PMC article.
Cited by
-
Changes in Pain Sensitivity in Treatment for Breast Cancer: A 12-Month Follow-Up Case Series.Int J Environ Res Public Health. 2022 Mar 29;19(7):4055. doi: 10.3390/ijerph19074055. Int J Environ Res Public Health. 2022. PMID: 35409738 Free PMC article.
-
Predictive factors for patients who need treatment for chronic post-surgical pain (CPSP) after breast cancer surgery.Breast Cancer. 2021 Nov;28(6):1346-1357. doi: 10.1007/s12282-021-01275-4. Epub 2021 Jul 22. Breast Cancer. 2021. PMID: 34292500
-
Predictors of persistent post-surgical pain intensity and interference at 1 year after breast cancer surgery: assessing central sensitization, central sensitivity symptoms, and psychological factors.Breast Cancer. 2023 Mar;30(2):271-281. doi: 10.1007/s12282-022-01420-7. Epub 2022 Dec 18. Breast Cancer. 2023. PMID: 36528837
-
Association of Aromatase Inhibitor-Induced Musculoskeletal Symptoms with Central Sensitization-Related Symptoms: A Cross-Sectional Study.Breast Care (Basel). 2024 Aug;19(4):207-214. doi: 10.1159/000539867. Epub 2024 Jun 18. Breast Care (Basel). 2024. PMID: 39185132 Free PMC article.
-
The Key Role of Emotional Repair and Emotional Clarity on Depression among Breast Cancer Survivors.Int J Environ Res Public Health. 2022 Apr 12;19(8):4652. doi: 10.3390/ijerph19084652. Int J Environ Res Public Health. 2022. PMID: 35457517 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical